Fda patent exclusivity news today?

I can help, but I need one quick detail: what do you mean by “FDA patent exclusivity”?

Today’s news could refer to any of these (each has different sources):
1) FDA “Orange Book” exclusivity (e.g., 5-year, 3-year, 7-year for certain drugs)
2) Patent exclusivity / patent listing events (Hatch-Waxman, 30-month stays, litigation-related updates)
3) New FDA actions from CDER or HHS announcements about exclusivity eligibility
4) A specific company/product name

Also, I don’t have live browsing in this chat, so I can’t reliably pull what happened “today” unless you paste a link/headline or tell me the drug/company.

If you paste the article text or link (or tell me the company + product), I’ll summarize what the FDA exclusivity means, the relevant exclusivity type/years, and what it likely impacts (generic entry timing, biosimilar timing, etc.).